Brief: Lisata Therapeutics Says On May 1, Eliminated Position Of President & Chief Business Officer
01/05/2023 23:02
May 1 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS - ON MAY 1, ELIMINATED POSITION OF
PRESIDENT
& CHIEF BUSINESS OFFICER, TERMINATED EMPLOYMENT OF DAVID SLACK,
EFFECTIVE IMMEDIATELY
Source text for Eikon: ID:
Further company coverage: LSTA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics Appoints Jeff Farrow To Board Of Directors
Brief: Lisata Therapeutics Announces New Method Of Use Patent Granted For Certepetide In The Treatment Of Pancreatic Cancer And Other Solid Tumors
NASDAQ RESUMED AT 09:55 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE -Expeditors International, Waters, Ameresco